Advertisement

Topics

Anika Therapeutics Incorporated Company Profile

04:45 EDT 24th September 2017 | BioPortfolio

Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products and devices intended to repair, protect and heal bone, cartilage and soft tissues. These products are currently derived from hyaluronic acid ("HA"), a naturally-occurring, biocompatible polymer found throughout the body. As suggested in the literature, the unique biophysical and biochemical properties of HA appear to play an important role in a number of physiological functions such as the protection, coating and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues, and the transport of molecules to specific anatomical sites.

Location

160 New Boston Street
Woburn
01801
United States of America

Contact

Phone: 935 932 6616
Fax: 781 935 4120


News Articles [1543 Associated News Articles listed on BioPortfolio]

Head-To-Head Survey: Anika Therapeutics (ANIK) versus Its Peers

Anika Therapeutics is one of 45 public companies in the "Biopharmaceuticals" industry, but how does it compare to its competitors? We will compare Anika Therapeutics to related companies based on the ...

Anika Therapeutics Announces First Patient Enrolled In Supplemental Phase III Trial Of CINGAL For The Treatment Of Knee Pain Associated With Osteoarthritis

BEDFORD, Mass.--(BUSINESS WIRE)--Anika ...

VP of regulatory, clinical affairs named by Anika Therapeutics

Steven Chartier was tapped to serve as vice president of regulatory and clinical affairs at Anika Therapeutics.  -More- 

Anika announces completion date of supplemental trial of knee pain drug

Anika Therapeutics said it anticipates completion of its supplemental late-stage trial of Cingal for osteoarthritis-related k -More- 

Anika to Issue Second-Quarter 2017 Financial Results and Business Highlights on Wednesday, July 26

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2017 financial results after the close of the market on Wednesday...

Anika to Present at the Singular Research Summer Solstice Conference on July 13, 2017

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") tec...

Anika Therapeutics: Robust Growth + Huge Margins At A Bargain Price

Anika Therapeutics (ANIK) Presents At Singular Summer Solstice Conference - Slideshow

Clinical Trials [117 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1180 Associated Companies listed on BioPortfolio]

Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing, repair and regenera...

Anika Therapeutics Incorporated

Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products and devices intended to repair, protect and heal bone, cartilage and soft tissues. These products are currently ...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Anika Therapeutics Incorporated" on BioPortfolio

We have published hundreds of Anika Therapeutics Incorporated news stories on BioPortfolio along with dozens of Anika Therapeutics Incorporated Clinical Trials and PubMed Articles about Anika Therapeutics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Anika Therapeutics Incorporated Companies in our database. You can also find out about relevant Anika Therapeutics Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...


Corporate Database Quicklinks



Searches Linking to this Company Record